| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 83.54B | 87.27B | 89.10B | 73.52B | 81.54B | 69.36B |
| Gross Profit | 72.30B | 76.34B | 79.16B | 62.62B | 72.45B | 60.38B |
| EBITDA | 15.66B | 20.94B | 22.05B | 9.66B | 21.01B | 16.16B |
| Net Income | 8.12B | 11.05B | 10.19B | 1.95B | 13.15B | 9.09B |
Balance Sheet | ||||||
| Total Assets | 1.22T | 1.41T | 1.40T | 1.06T | 1.58T | 1.42T |
| Cash, Cash Equivalents and Short-Term Investments | 404.50B | 531.91B | 417.00B | 392.46B | 618.89B | 666.98B |
| Total Debt | 650.49B | 388.26B | 643.97B | 521.81B | 752.38B | 752.16B |
| Total Liabilities | 1.03T | 1.21T | 1.21T | 874.67B | 1.40T | 1.24T |
| Stockholders Equity | 178.94B | 181.92B | 180.27B | 169.83B | 173.23B | 166.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 20.39B | 10.61B | 104.19B | 1.49B | -75.27B |
| Operating Cash Flow | 0.00 | 20.78B | 12.81B | 107.31B | 5.67B | -73.07B |
| Investing Cash Flow | -24.36B | -24.36B | -42.57B | -18.62B | -23.01B | -12.40B |
| Financing Cash Flow | 17.66B | 17.66B | -4.53B | -57.59B | 32.35B | 104.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥60.61B | 10.05 | 17.21% | 4.27% | 7.60% | 7.20% | |
76 Outperform | ¥46.99B | 7.03 | 6.18% | 4.42% | 1.56% | -9.90% | |
72 Outperform | ¥1.97T | 3.01 | 20.02% | 2.63% | 23.96% | 179.16% | |
72 Outperform | ¥188.51B | 7.61 | 7.40% | 5.60% | 3.10% | 17.73% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥121.76B | 8.60 | 5.11% | 5.07% | -19.64% | -31.08% | |
53 Neutral | ¥27.41B | -8.03 | ― | ― | -33.10% | -49.56% |